Cantor Fitzgerald Reiterates Overweight on Invivyd, Maintains $10 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 65.1%

Neg 0% Neu 65.1% Pos 0%

Cantor Fitzgerald analyst Josh Schimmer reiterates Invivyd (NASDAQ:IVVD) with a Overweight and maintains $10 price target.